Works matching IS 03407004 AND DT 2015 AND VI 64 AND IP 10
Results: 13
Novel strategies for inhibiting PD-1 pathway-mediated immune suppression while simultaneously delivering activating signals to tumor-reactive T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1287, doi. 10.1007/s00262-015-1677-5
- By:
- Publication type:
- Article
A combined approach of human leukocyte antigen ligandomics and immunogenicity analysis to improve peptide-based cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1295, doi. 10.1007/s00262-015-1682-8
- By:
- Publication type:
- Article
Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1305, doi. 10.1007/s00262-015-1698-0
- By:
- Publication type:
- Article
Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1315, doi. 10.1007/s00262-015-1724-2
- By:
- Publication type:
- Article
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1271, doi. 10.1007/s00262-015-1729-x
- By:
- Publication type:
- Article
TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1229, doi. 10.1007/s00262-015-1730-4
- By:
- Publication type:
- Article
A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1251, doi. 10.1007/s00262-015-1731-3
- By:
- Publication type:
- Article
Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1215, doi. 10.1007/s00262-015-1733-1
- By:
- Publication type:
- Article
Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1329, doi. 10.1007/s00262-015-1734-0
- By:
- Publication type:
- Article
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1241, doi. 10.1007/s00262-015-1735-z
- By:
- Publication type:
- Article
Expansion of myeloid-derived suppressor cells in chronic obstructive pulmonary disease and lung cancer: potential link between inflammation and cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1261, doi. 10.1007/s00262-015-1737-x
- By:
- Publication type:
- Article
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1339, doi. 10.1007/s00262-015-1747-8
- By:
- Publication type:
- Article
The Fourteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-14), September 24-26, 2014, Rome, Italy: rethinking anti-tumor vaccines in a new era of cancer immunotherapy.
- Published in:
- 2015
- By:
- Publication type:
- Report